{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T10:30:11Z","timestamp":1794479411417,"version":"4.9.1"},"reference-count":77,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T00:00:00Z","timestamp":1776816000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100021795","name":"Khon Kaen University Cholangiocarcinoma Research Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100021795","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004071","name":"Khon Kaen University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004071","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.biopha.2026.119438","type":"journal-article","created":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T10:15:42Z","timestamp":1777284942000},"page":"119438","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Preclinical demonstration of the efficacy and mechanisms of antitumor activity of dihydroartemisinin in cholangiocarcinoma xenograft: Induction of autophagy and reprogramming of metabolism"],"prefix":"10.1016","volume":"199","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3159-0464","authenticated-orcid":false,"given":"Suyanee","family":"Thongchot","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-8447-3790","authenticated-orcid":false,"given":"Yingpinyapat","family":"Kittirat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-7150-8924","authenticated-orcid":false,"given":"Bundit","family":"Promraksa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7192-9672","authenticated-orcid":false,"given":"Alessandra","family":"Ferraresi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Vidoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Watcharin","family":"Loilome","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nisana","family":"Namwat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5494-3034","authenticated-orcid":false,"given":"Ciro","family":"Isidoro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.biopha.2026.119438_bib1","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1053\/j.gastro.2013.10.013","article-title":"Pathogenesis, diagnosis, and management of cholangiocarcinoma","volume":"145","author":"Ilyas","year":"2013","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.biopha.2026.119438_bib2","doi-asserted-by":"crossref","first-page":"801","DOI":"10.3390\/cancers16040801","article-title":"Cholangiocarcinoma: recent advances in molecular pathobiology and therapeutic approaches","volume":"16","author":"Khosla","year":"2024","journal-title":"Cancers"},{"issue":"3","key":"10.1016\/j.biopha.2026.119438_bib3","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1097\/MOG.0b013e3282fbf9b3","article-title":"Cholangiocarcinoma: lessons from Thailand","volume":"24","author":"Sripa","year":"2008","journal-title":"Curr. Opin. Gastroenterol."},{"issue":"5","key":"10.1016\/j.biopha.2026.119438_bib4","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/nrgastro.2016.51","article-title":"Expert consensus document: Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA)","volume":"13","author":"Banales","year":"2016","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.biopha.2026.119438_bib5","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1007\/s11894-011-0178-8","article-title":"Cholangiocarcinoma: epidemiology, risk factors, pathogenesis, and diagnosis","volume":"13","author":"Charbel","year":"2011","journal-title":"Curr. Gastroenterol. Rep."},{"key":"10.1016\/j.biopha.2026.119438_bib6","doi-asserted-by":"crossref","first-page":"v28","DOI":"10.1093\/annonc\/mdw324","article-title":"Oncology, Biliary cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"27","author":"Valle","year":"2016","journal-title":"Ann. Oncol."},{"issue":"1","key":"10.1016\/j.biopha.2026.119438_bib7","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/s41392-025-02148-4","article-title":"Invasion and metastasis in cancer: molecular insights and therapeutic targets","volume":"10","author":"Li","year":"2025","journal-title":"Signal Transduct. Target Ther."},{"issue":"9","key":"10.1016\/j.biopha.2026.119438_bib8","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/s41575-020-0310-z","article-title":"Cholangiocarcinoma 2020: the next horizon in mechanisms and management","volume":"17","author":"Banales","year":"2020","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"1","key":"10.1016\/j.biopha.2026.119438_bib9","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.cmet.2015.12.006","article-title":"The emerging hallmarks of cancer metabolism","volume":"23","author":"Pavlova","year":"2016","journal-title":"Cell Metab."},{"issue":"1","key":"10.1016\/j.biopha.2026.119438_bib10","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nrclinonc.2016.60","article-title":"Cancer metabolism: a therapeutic perspective","volume":"14","author":"Martinez-Outschoorn","year":"2017","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"5930","key":"10.1016\/j.biopha.2026.119438_bib11","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1126\/science.1160809","article-title":"Understanding the Warburg effect: the metabolic requirements of cell proliferation","volume":"324","author":"Vander Heiden","year":"2009","journal-title":"Science"},{"issue":"5","key":"10.1016\/j.biopha.2026.119438_bib12","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.1600200","article-title":"Fundamentals of cancer metabolism","volume":"2","author":"DeBerardinis","year":"2016","journal-title":"Sci. Adv."},{"issue":"2","key":"10.1016\/j.biopha.2026.119438_bib13","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/s41573-021-00339-6","article-title":"Targeting cancer metabolism in the era of precision oncology","volume":"21","author":"Stine","year":"2022","journal-title":"Nat. Rev. Drug Discov."},{"issue":"6","key":"10.1016\/j.biopha.2026.119438_bib14","doi-asserted-by":"crossref","first-page":"3670","DOI":"10.1016\/j.bbagen.2013.02.008","article-title":"Natural products: a continuing source of novel drug leads","volume":"1830","author":"Cragg","year":"2013","journal-title":"Biochim. Biophys. Acta"},{"issue":"3","key":"10.1016\/j.biopha.2026.119438_bib15","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1021\/acs.jnatprod.9b01285","article-title":"Natural products as sources of new drugs over the nearly four decades from 01\/1981 to 09\/2019","volume":"83","author":"Newman","year":"2020","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.biopha.2026.119438_bib16","series-title":"Seminars in cancer biology","first-page":"34","article-title":"Epigenetic targeting of autophagy for cancer prevention and treatment by natural compounds","author":"Vidoni","year":"2020"},{"key":"10.1016\/j.biopha.2026.119438_bib17","first-page":"160","article-title":"Resveratrol interrupts the pro-invasive communication between cancer associated fibroblasts and cholangiocarcinoma cells","volume":"430","author":"Thongchot","year":"2018","journal-title":"Mol. Carcinog."},{"key":"10.1016\/j.biopha.2026.119438_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2023.216589","article-title":"Preclinical evidence for preventive and curative effects of resveratrol on xenograft cholangiocarcinogenesis","volume":"582","author":"Thongchot","year":"2024","journal-title":"Cancer Lett."},{"issue":"1","key":"10.1016\/j.biopha.2026.119438_bib19","first-page":"1080","article-title":"Herbal medicine dihydroartemisinin inhibits colorectal cancer by Regulating PI3K\/AKT signal-ing pathway","volume":"3","author":"Xu","year":"2023","journal-title":"J. Oncol."},{"issue":"24","key":"10.1016\/j.biopha.2026.119438_bib20","doi-asserted-by":"crossref","first-page":"6057","DOI":"10.7150\/jca.33704","article-title":"Dihydroartemisinin induces endothelial cell autophagy through suppression of the Akt\/mTOR pathway","volume":"10","author":"Liu","year":"2019","journal-title":"J. Cancer"},{"issue":"12","key":"10.1016\/j.biopha.2026.119438_bib21","first-page":"1735","article-title":"Dihydroartemisinin induces apoptosis and autophagy-dependent cell death in cholangiocarcinoma through a DAPK1-BECLIN1 pathway","volume":"57","author":"Thongchot","year":"2018","journal-title":"Cancer Lett."},{"issue":"1","key":"10.1016\/j.biopha.2026.119438_bib22","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-025-15969-8","article-title":"Dihydroartemisinin induces tumor suppression in the Drosophila brain tumor with functional recovery and a rescue in lethality","volume":"15","author":"Sulava","year":"2025","journal-title":"Sci. Rep."},{"issue":"10","key":"10.1016\/j.biopha.2026.119438_bib23","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.2174\/1389201024666230821155243","article-title":"Anticancer effect of dihydroartemisinin via dual control of ROS-induced apoptosis and protective autophagy in prostate cancer 22Rv1 cells","volume":"25","author":"Yang","year":"2024","journal-title":"Curr. Pharm. Biotechnol."},{"issue":"6","key":"10.1016\/j.biopha.2026.119438_bib24","doi-asserted-by":"crossref","first-page":"3023","DOI":"10.1002\/med.21842","article-title":"The immunosuppressive activity of artemisinin-type drugs towards inflammatory and autoimmune diseases","volume":"41","author":"Efferth","year":"2021","journal-title":"Med. Res. Rev."},{"issue":"11","key":"10.1016\/j.biopha.2026.119438_bib25","doi-asserted-by":"crossref","first-page":"3466","DOI":"10.3390\/ijms19113466","article-title":"The roles of autophagy in cancer","volume":"19","author":"Yun","year":"2018","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.biopha.2026.119438_bib26","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1242\/jcs.064576","article-title":"The regulation of autophagy\u2013unanswered questions","volume":"124","author":"Chen","year":"2011","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.biopha.2026.119438_bib27","article-title":"Growth rate analysis and efficient experimental design for tumor xenograft studies: supplementary issue: array platform modeling and analysis (A)","volume":"13","author":"Hather","year":"2014","journal-title":"Cancer Inf."},{"issue":"18","key":"10.1016\/j.biopha.2026.119438_bib28","doi-asserted-by":"crossref","first-page":"2847","DOI":"10.1093\/bioinformatics\/btw313","article-title":"Complex heatmaps reveal patterns and correlations in multidimensional genomic data","volume":"32","author":"Gu","year":"2016","journal-title":"Bioinformatics"},{"key":"10.1016\/j.biopha.2026.119438_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2020.107517","article-title":"Therapeutics, The choice for the optimal therapy in advanced biliary tract cancers: chemotherapy, targeted therapies or immunotherapy","volume":"210","author":"Palmieri","year":"2020","journal-title":"Pharm. Ther."},{"issue":"1","key":"10.1016\/j.biopha.2026.119438_bib30","doi-asserted-by":"crossref","first-page":"13","DOI":"10.5009\/gnl15568","article-title":"liver, Cholangiocarcinoma: current knowledge and new developments","volume":"11","author":"Blechacz","year":"2016","journal-title":"Gut Liver"},{"issue":"4","key":"10.1016\/j.biopha.2026.119438_bib31","doi-asserted-by":"crossref","first-page":"579","DOI":"10.14740\/wjon1895","article-title":"Impact of lymph node dissection for patients with clinically node-negative intrahepatic cholangiocarcinoma: a multicenter cohort study","volume":"15","author":"Sha","year":"2024","journal-title":"World J. Oncol."},{"key":"10.1016\/j.biopha.2026.119438_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2022.101514","article-title":"Targeting tumor microenvironment for cholangiocarcinoma: opportunities for precision medicine","volume":"25","author":"Carloni","year":"2022","journal-title":"Transl. Oncol."},{"issue":"15","key":"10.1016\/j.biopha.2026.119438_bib33","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.3390\/cells11152262","article-title":"L.O. Soto-Rojas, Autophagy: a key regulator of homeostasis and disease: an overview of molecular mechanisms and modulators","volume":"11","author":"G\u00f3mez-Virgilio","year":"2022","journal-title":"Cells"},{"issue":"10","key":"10.1016\/j.biopha.2026.119438_bib34","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1038\/s41419-023-06154-8","article-title":"disease, autophagy: regulator of cell death","volume":"14","author":"Liu","year":"2023","journal-title":"Cell Death Dis."},{"issue":"1","key":"10.1016\/j.biopha.2026.119438_bib35","doi-asserted-by":"crossref","first-page":"179","DOI":"10.3390\/ijms22010179","article-title":"The dual role of autophagy in cancer development and a therapeutic strategy for cancer by targeting autophagy","volume":"22","author":"Yun","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.biopha.2026.119438_bib36","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.ceb.2009.12.002","article-title":"Cytoprotective roles for autophagy","volume":"22","author":"Moreau","year":"2010","journal-title":"Curr. Opin. Cell Biol."},{"issue":"3","key":"10.1016\/j.biopha.2026.119438_bib37","first-page":"614","article-title":"Therapeutic potential of autophagy modulation in cholangiocarcinoma","volume":"9","author":"Perez-Montoyo","year":"2020","journal-title":"Cancers"},{"issue":"1","key":"10.1016\/j.biopha.2026.119438_bib38","doi-asserted-by":"crossref","first-page":"18","DOI":"10.3390\/cancers10010018","article-title":"mTOR pathways in cancer and autophagy","volume":"10","author":"Paquette","year":"2018","journal-title":"Cancers"},{"issue":"6","key":"10.1016\/j.biopha.2026.119438_bib39","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.3390\/cells10061363","article-title":"Dihydroartemisinin inhibits mTORC1 signaling by activating the AMPK pathway in rhabdomyosarcoma tumor cells","volume":"10","author":"Luo","year":"2021","journal-title":"Cells"},{"issue":"3","key":"10.1016\/j.biopha.2026.119438_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2025.e42095","article-title":"Dihydroartemisinin inhibits EphA2\/PI3K\/Akt pathway-mediated malignant behaviors and vasculogenic mimicry in glioma stem cells","volume":"11","author":"Fu","year":"2025","journal-title":"Heliyon"},{"key":"10.1016\/j.biopha.2026.119438_bib41","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.jnutbio.2018.05.009","article-title":"Mechanisms of DHA-enriched phospholipids in improving cognitive deficits in aged SAMP8 mice with high-fat diet","volume":"59","author":"Zhou","year":"2018","journal-title":"J. Nutr. Biochem."},{"issue":"20","key":"10.1016\/j.biopha.2026.119438_bib42","doi-asserted-by":"crossref","first-page":"3380","DOI":"10.1080\/10408398.2018.1492901","article-title":"Nutrition, Effects of EPA and DHA on blood pressure and inflammatory factors: a meta-analysis of randomized controlled trials","volume":"59","author":"Guo","year":"2019","journal-title":"Crit. Rev. Food Sci. Nutr."},{"key":"10.1016\/j.biopha.2026.119438_bib43","doi-asserted-by":"crossref","first-page":"3123","DOI":"10.1007\/s10620-006-9681-4","article-title":"sciences, Incidence, diagnosis, and therapy of cholangiocarcinoma in patients with primary sclerosing cholangitis","volume":"52","author":"Fevery","year":"2007","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.biopha.2026.119438_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.jnutbio.2019.108245","article-title":"Omega-3 polyunsaturated fatty acids suppress metastatic features of human cholangiocarcinoma cells by suppressing twist","volume":"74","author":"Lin","year":"2019","journal-title":"J. Nutr. Biochem."},{"issue":"4","key":"10.1016\/j.biopha.2026.119438_bib45","doi-asserted-by":"crossref","first-page":"94","DOI":"10.3892\/ol.2020.11955","article-title":"Dihydroartemisinin inhibits the migration of esophageal cancer cells by inducing autophagy","volume":"20","author":"Chen","year":"2020","journal-title":"Oncol. Lett."},{"issue":"9","key":"10.1016\/j.biopha.2026.119438_bib46","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1038\/ncb0910-823","article-title":"Autophagy in mammalian development and differentiation","volume":"12","author":"Mizushima","year":"2010","journal-title":"Nat. Cell Biol."},{"issue":"19","key":"10.1016\/j.biopha.2026.119438_bib47","doi-asserted-by":"crossref","DOI":"10.15252\/embj.2021108863","article-title":"Autophagy in major human diseases","volume":"40","author":"Klionsky","year":"2021","journal-title":"EMBO J."},{"issue":"1","key":"10.1016\/j.biopha.2026.119438_bib48","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1172\/JCI73941","article-title":"The role for autophagy in cancer","volume":"125","author":"White","year":"2015","journal-title":"J. Clin. Invest."},{"issue":"2","key":"10.1016\/j.biopha.2026.119438_bib49","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.molcel.2010.09.023","article-title":"Autophagy and the integrated stress response","volume":"40","author":"Kroemer","year":"2010","journal-title":"Mol. Cell"},{"issue":"12","key":"10.1016\/j.biopha.2026.119438_bib50","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1093\/abbs\/gmy125","article-title":"Artemisinin derivatives inhibit epithelial ovarian cancer cells via autophagy-mediated cell cycle arrest","volume":"50","author":"Li","year":"2018","journal-title":"Acta Biochim. Biophys. Sin."},{"issue":"15","key":"10.1016\/j.biopha.2026.119438_bib51","doi-asserted-by":"crossref","first-page":"5378","DOI":"10.3390\/ijms21155378","article-title":"Molecular mechanisms underlying hepatocellular carcinoma induction by aberrant NRF2 activation-mediated transcription networks: interaction of NRF2-KEAP1 controls the fate of hepatocarcinogenesis","volume":"21","author":"Haque","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"12","key":"10.1016\/j.biopha.2026.119438_bib52","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.3390\/cancers11122002","article-title":"JAK-STAT signaling: a double-edged sword of immune regulation and cancer progression","volume":"11","author":"Owen","year":"2019","journal-title":"Cancers"},{"key":"10.1016\/j.biopha.2026.119438_bib53","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.3389\/fphar.2019.01292","article-title":"Rapamycin attenuates high glucose-induced inflammation through modulation of mTOR\/NF-\u03baB pathways in macrophages","volume":"10","author":"Dai","year":"2019","journal-title":"Front Pharm."},{"issue":"1","key":"10.1016\/j.biopha.2026.119438_bib54","doi-asserted-by":"crossref","first-page":"37","DOI":"10.3390\/metabo10010037","article-title":"Metabolomics in the context of plant natural products research: From sample preparation to metabolite analysis","volume":"10","author":"Salem","year":"2020","journal-title":"Metabolites"},{"issue":"3215","key":"10.1016\/j.biopha.2026.119438_bib55","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1126\/science.124.3215.269","article-title":"On respiratory impairment in cancer cells","volume":"124","author":"Warburg","year":"1956","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.biopha.2026.119438_bib56","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.cmet.2007.10.002","article-title":"The biology of cancer: metabolic reprogramming fuels cell growth and proliferation","volume":"7","author":"DeBerardinis","year":"2008","journal-title":"Cell Metab."},{"issue":"4","key":"10.1016\/j.biopha.2026.119438_bib57","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.3390\/cancers15041070","article-title":"Mitochondrial metabolism in pancreatic ductal adenocarcinoma: from mechanism-based perspectives to therapy","volume":"15","author":"Padinharayil","year":"2023","journal-title":"Cancers"},{"issue":"11","key":"10.1016\/j.biopha.2026.119438_bib58","doi-asserted-by":"crossref","first-page":"5704","DOI":"10.1002\/cam4.1827","article-title":"Dihydroartemisinin induces apoptosis and inhibits proliferation, migration, and invasion in epithelial ovarian cancer via inhibition of the hedgehog signaling pathway","volume":"7","author":"Liu","year":"2018","journal-title":"Cancer Med."},{"key":"10.1016\/j.biopha.2026.119438_bib59","first-page":"1","article-title":"Reports, metabolic control of stem cell function: insights into amino acid-driven mechanisms","author":"Zeng","year":"2025","journal-title":"Stem Cell Rev. Rep."},{"issue":"3","key":"10.1016\/j.biopha.2026.119438_bib60","doi-asserted-by":"crossref","first-page":"260","DOI":"10.3390\/biom14030260","article-title":"Tricarboxylic acid cycle intermediates and individual ageing","volume":"14","author":"Kurhaluk","year":"2024","journal-title":"Biomolecules"},{"issue":"10","key":"10.1016\/j.biopha.2026.119438_bib61","doi-asserted-by":"crossref","first-page":"2862","DOI":"10.3390\/cancers15102862","article-title":"Succinate-directed approaches for Warburg effect-targeted cancer management, an alternative to current treatments?","volume":"15","author":"Casas-Benito","year":"2023","journal-title":"Cancers"},{"issue":"8","key":"10.1016\/j.biopha.2026.119438_bib62","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1038\/s41574-020-0365-5","article-title":"Creatine metabolism: energy homeostasis, immunity and cancer biology","volume":"16","author":"Kazak","year":"2020","journal-title":"Nat. Rev. Endocrinol."},{"issue":"8","key":"10.1016\/j.biopha.2026.119438_bib63","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1007\/s00726-016-2217-0","article-title":"Creatine kinase in cell cycle regulation and cancer","volume":"48","author":"Yan","year":"2016","journal-title":"Amino Acids"},{"issue":"2","key":"10.1016\/j.biopha.2026.119438_bib64","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1038\/s41416-019-0620-5","article-title":"New aspects of amino acid metabolism in cancer","volume":"122","author":"Vettore","year":"2020","journal-title":"Br. J. Cancer"},{"issue":"11","key":"10.1016\/j.biopha.2026.119438_bib65","doi-asserted-by":"crossref","first-page":"2701","DOI":"10.1089\/ars.2009.2692","article-title":"Adaptation to oxidative stress, chemoresistance, and cell survival","volume":"11","author":"Landriscina","year":"2009","journal-title":"Antioxid. Redox Signal"},{"issue":"2","key":"10.1016\/j.biopha.2026.119438_bib66","doi-asserted-by":"crossref","first-page":"488","DOI":"10.5114\/aoms\/111947","article-title":"Induction of apoptosis in RL95-2 human endometrial cancer cells by combination treatment with docosahexaenoic acid and triacsin C","volume":"19","author":"Chung","year":"2021","journal-title":"Arch. Med. Sci."},{"issue":"1","key":"10.1016\/j.biopha.2026.119438_bib67","article-title":"The omega-3 polyunsaturated fatty acid DHA induces simultaneous apoptosis and autophagy via mitochondrial ROS-mediated Akt-mTOR signaling in prostate cancer cells expressing mutant p53","volume":"2013","author":"Shin","year":"2013","journal-title":"Biomed. Res. Int."},{"issue":"1","key":"10.1016\/j.biopha.2026.119438_bib68","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s40170-024-00348-0","article-title":"Metabolism, The polyunsaturated fatty acid docosahexaenoic affects mitochondrial function in prostate cancer cells","volume":"12","author":"Tamarindo","year":"2024","journal-title":"Cancer Metab."},{"issue":"1","key":"10.1016\/j.biopha.2026.119438_bib69","article-title":"C. Oncology, Amino acid deprivation in cancer cells with compensatory autophagy induction increases sensitivity to autophagy inhibitors","volume":"11","author":"Fukui","year":"2024","journal-title":"Mol. Cell Oncol."},{"issue":"2","key":"10.1016\/j.biopha.2026.119438_bib70","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1038\/s41419-021-03456-7","article-title":"disease, BCAT1 decreases the sensitivity of cancer cells to cisplatin by regulating mTOR-mediated autophagy via branched-chain amino acid metabolism","volume":"12","author":"Luo","year":"2021","journal-title":"Cell Death Dis."},{"issue":"1","key":"10.1016\/j.biopha.2026.119438_bib71","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.pharmthera.2013.12.001","article-title":"therapeutics, Artemisinins: pharmacological actions beyond anti-malarial","volume":"142","author":"Ho","year":"2014","journal-title":"Pharm. Ther."},{"key":"10.1016\/j.biopha.2026.119438_bib72","series-title":"Semin Cancer Biol","first-page":"65","article-title":"From ancient herb to modern drug: Artemisia annua and artemisinin for cancer therapy, Seminars in cancer biology","author":"Efferth","year":"2017"},{"issue":"6","key":"10.1016\/j.biopha.2026.119438_bib73","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1016\/j.jhep.2014.01.021","article-title":"Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma","volume":"60","author":"Bridgewater","year":"2014","journal-title":"J. Hepatol."},{"issue":"17","key":"10.1016\/j.biopha.2026.119438_bib74","doi-asserted-by":"crossref","first-page":"8409","DOI":"10.3390\/ijms26178409","article-title":"Artemisinin and its derivatives from molecular mechanisms to clinical applications: new horizons beyond antimalarials","volume":"26","author":"Xia","year":"2025","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.biopha.2026.119438_bib75","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/j.jhep.2022.04.038","article-title":"Metabolic reprogramming in cholangiocarcinoma","volume":"77","author":"Raggi","year":"2022","journal-title":"J. Hepatol."},{"issue":"11","key":"10.1016\/j.biopha.2026.119438_bib76","doi-asserted-by":"crossref","first-page":"600","DOI":"10.5483\/BMBRep.2023-0029","article-title":"Regulation of glucose and glutamine metabolism to overcome cisplatin resistance in intrahepatic cholangiocarcinoma","volume":"56","author":"Yang","year":"2023","journal-title":"BMB Rep."},{"issue":"1","key":"10.1016\/j.biopha.2026.119438_bib77","article-title":"Combinatorial treatment with natural compounds in prostate cancer inhibits prostate tumor growth and leads to key modulations of cancer cell metabolism","volume":"1","author":"Lodi","year":"2017","journal-title":"NPJ Precis Oncol."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332226004749?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332226004749?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T09:47:27Z","timestamp":1794476847000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332226004749"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":77,"alternative-id":["S0753332226004749"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2026.119438","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Preclinical demonstration of the efficacy and mechanisms of antitumor activity of dihydroartemisinin in cholangiocarcinoma xenograft: Induction of autophagy and reprogramming of metabolism","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2026.119438","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"119438"}}